Jason Laine

Medicinal Cannabis Breakthrough: A Game-Changer for Tourette Syndrome Patients 0
- CANNABIS OIL
- December 5, 2024
A groundbreaking clinical trial has revealed that medicinal cannabis could be a life-altering treatment for individuals suffering from Tourette syndrome. The study, published in the New England Journal of Medicine: Evidence, demonstrated a significant reduction in motor and vocal tics in just six weeks. Led by Dr. Philip Mosley and co-funded by the University of
READ MORE
DEA Postpones Marijuana Rescheduling Decision, Sparking Election-Year Debate 0
- MEDICAL MARIJUANA
- December 2, 2024
The Drug Enforcement Administration (DEA) has announced a significant delay in its decision on marijuana rescheduling, pushing the timeline beyond the upcoming presidential election. According to a recent Forbes report, the DEA has scheduled a hearing for December 2 to discuss the Biden administration’s proposal to reclassify marijuana under federal drug laws. This move effectively
READ MORE

New Publication Highlights Role of Medical Cannabis in Epilepsy Treatment 0
- CANNABIS OIL
- November 25, 2024
A groundbreaking review titled Medical Cannabis & Epilepsy has been released by Maple Tree Consultants, providing a comprehensive analysis of the role of cannabis-based medicines in managing epilepsy. This publication, co-authored by experts including Professor Mike Barnes and Hannah Deacon, compiles findings from nearly 100 clinical trials and observational studies, making it an invaluable resource
READ MORE
Florida’s Medical Cannabis Market Shows Signs of Cooling 0
- MEDICAL MARIJUANA
- November 18, 2024
Recent data from Florida’s Office of Medical Marijuana Use reveals a significant slowdown in the state’s medical cannabis market. Patient growth has decelerated to a record low of 2.7% annually, down from 8.4% in late May. Despite an increase in dispensaries, the market is facing challenges with slowing revenue growth and increasing competition. Interestingly, unit
READ MORE